CytomX Therapeutics, Inc.
-
Ticker
CTMX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in South San Francisco, California
CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with their novel Probody™ therapeutic platform. Their commitment to transforming lives with safer, more effective therapies is driven by their curiosity and passion for innovation and their belief that by acting with integrity in an honest, respectful, ethical manner, they have the power to change lives. Their workplace
…More embodies collaboration, open communication, celebrating their successes and holding each other to the highest possible standards. CytomX has a broad pipeline comprised of 4 clinical-stage programs and others in development and is located in South San Francisco, California, the birthplace of biotechnology.
REPORT RATINGS
4.8 / 5.0 (181)
CytomX Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 181 reviews.
CytomX Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports